Benedetti et al. [30] attributed the anticancer effects of acyclovir against NCI-H1975 lung cancer cells to acyclovir’s role in mitochondrial DNA damage and activation of caspase-3, which triggers apoptosis in cancer cells. Here, CASP3 is linked to lung cancer.